ENTA position history
The shares of Enanta Pharmaceuticals (ENTA) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 150,000 shares, $2.4M, 0.31% of portfolio, New
- 2026 Q1: 125,000 shares, $1.6M, 0.21% of portfolio, Reduce −16.7%
- 2026 Q2: 125,000 shares, $1.8M, 0.17% of portfolio
- 2026 Q3: 125,000 shares, $1.6M, 0.19% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|